MTP inhibitors (Astellas)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameMTP inhibitors (Astellas)

Drug Alias Namemicrosomal triglyceride transfer protein inhibitors (Astellas)AS-1552133AS-1512680

ClassificationSmall molecules

Mechanisms of ActionMicrosomal triglyceride transfer protein inhibitors

TargetsMicrosomal triglyceride transfer protein

Therapy Area/IndicationsHypercholesterolemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAstellas Pharma Inc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsHypercholesterolemia

ATC CodeN/A